Mental health
CHAPTER 16 Β· PSYCHIATRIC MENTAL HEALTH NURSING
Schizophrenia Spectrum Disorders
Positive & negative symptoms, neurobiology, antipsychotic pharmacology, EPS, NMS, and priority nursing interventions.
π 30-min teachable
π 1st vs 2nd gen antipsychotics
β EPS & NMS priority
π― NCLEX-focused
β Fully editable
π
Overview & Spectrum Disorders
β± 0β3 min
π
Schizophrenia β DSM-5 Diagnostic Criteria (Know the Numbers!)
Two or more of the following for at least 1 month (at least one must be #1, #2, or #3): (1) Delusions, (2) Hallucinations, (3) Disorganized speech, (4) Grossly disorganized or catatonic behavior, (5) Negative symptoms. Continuous signs of disturbance persist for at least 6 months.
π Schizophrenia Spectrum β Related Disorders
Schizophreniaβ 6+ months total; 1+ month active symptoms Schizophreniform Disorderβ same criteria but duration at least 1 month-less than 6 months; may resolve Brief Psychotic Disorderβ sudden onset; duration <1 month; often stress-triggered Schizoaffective Disorderβ schizophrenia symptoms + major mood episode (depression or mania); at least 2 weeks of hallucinations or delusions without mood symptoms, mood symptoms must be present for majority of illness DelusionalΒ Disorderβ one or more delusions for at least 1 month. Function not impaired, no hallucinations, persecutory, erotomanic, grandiose, jealous, somaticSchizotypal personality disorder- odd eccentric behaviors, transient psychotic symptoms
π Epidemiology & Course
Affects approximately 1% of the world population Onset: typically late adolescence or early adulthood; earlier in males Males: earlier onset (15-25), more severe negative symptoms Females: later onset (25-35), better prognosis overall Chronic, relapsing course β requires long-term management Medication non-adherence is the leading cause of relapse Comorbidities: substance use disorders, depression, anxiety; high suicide risk
π‘
The most common trigger for relapse in schizophrenia is medication non-adherence. Long-acting injectable (LAI) antipsychotics are a key strategy to address this. This is a priority nursing education topic.
β‘
Positive vs. Negative Symptoms β Most Tested!
β± 3β8 min
π―
Memory Hook: Positive = Added; Negative = Removed
Positive symptoms are behaviors or experiences added to the person's baseline β things that should NOT be there. Negative symptoms are behaviors or functions removed from the person β things that SHOULD be there but are absent. Negative symptoms are harder to treat and have greater impact on daily functioning and quality of life.
π΄ Positive Symptoms
Hallucinationsβ false sensory perceptions without external stimulus, do not exist in realityΒ
Delusionsβ fixed false beliefs that have no basis in realityΒ (persecutory most common)Disorganized speech/thinkingβ loose associations (fragmented thoughts or ideas), tangential, flight of ideas Disorganized behaviorβ unpredictable, agitated, inappropriate affect,Β Catatoniaβ extremes: stupor/waxy flexibility OR excessive motor activityΒ Ambivalence: Holding seemingly contradictory beliefs or feelings about the same person, event, or situationΒ Β Β
Respond to antipsychotics
Acute crisis focus
π΅ Negative SymptomsΒ
Affect (flat)Β β diminished emotional expression; monotone voice, blank faceΒ Blunted affect-restricted range of emotional feeling, tone, or mood
Β Β
Alogiaβ poverty of speech, decrease amount, fluency, or spontaneity of speech Avolitionβ absence of will, ambition, or drive; lack of motivation Anhedoniaβ inability to experience pleasure or joy from previously enjoyed activitiesΒ Inattention: Inability to concentrate or focus on a topic or activity, regardless of its importanceAsocialityβ social withdrawal; lack of desire for social interaction
Harder to treat
Atypicals more effective
Greater functional impact
π Cognitive Symptoms β Often Overlooked
Impaired working memory β cannot hold information to complete a task Poor attention and concentration Concrete thinking β cannot think abstractly; interprets idioms literally
Executive function deficits β difficulty planning, problem-solving, decision-making Slow processing speed Cognitive deficits present before psychosis and are linked to poor functional outcomes
π
Hallucinations & Delusions
β± 8β12 min
π Types of Hallucinations
Auditoryβ most common in schizophrenia; hearing voices; voices may give commands (command hallucinationsβ assess safety immediately!) Visualβ seeing things not there; more common in delirium than schizophrenia Tactileβ feeling sensations on or under skin (formication β "bugs crawling") Olfactoryβ smelling odors others cannot detect Gustatoryβ tasting things without a stimulus
π§© Types of Delusions
Persecutoryβ most common; belief of being followed, spied on, poisoned, or harassed Grandioseβ belief of having exceptional power, wealth, or identity (e.g., "I am the president") Referential (Ideas of Reference)β belief that neutral stimuli (TV, radio) send personal messages Somaticβ false belief about body or bodily functions Erotomanicβ false belief that someone (often famous) is in love with them Nihilisticβ belief that self, others, or the world does not exist or will be destroyed
π¨
Priority Assessment: Command Hallucinations
When a patient reports hearing voices, always ask: "What are the voices telling you to do?" Command hallucinations that instruct the patient to harm themselves or others require immediate safety assessment and intervention. This is the nurse's legal and ethical priority.
π¬ Therapeutic Responses β Hallucinations & Delusions
π Responding to Hallucinations
Do NOT pretend to see/hear what the patient perceives Do NOT argue or challenge the reality of the experience Acknowledge the patient's experience: "I don't hear the voices, but I can see they are frightening you."Focus on feelings: "That sounds very scary. You are safe here."Redirect to present activity or environment Assess for command hallucinations β safety first
π§© Responding to Delusions
Do NOT agree with or reinforce the delusion Do NOT directly argue or try to convince patient the belief is false Acknowledge the feeling behind the delusion: "It sounds like you feel very unsafe."Focus on reality-based aspects of the conversation Avoid detailed discussion of the delusional content Maintain consistent, calm, non-threatening approach
π
Thought Process Disturbances
β± 12β14 min
π Disordered Thought Processes
Loose associationsβ ideas shift from topic to topic with no logical connection Tangential thinkingβ responses go off on a tangent and never return to the point Circumstantial thinkingβ eventually gets to the point but through excessive, unnecessary detail Flight of ideasβ rapid, continuous speech jumping between loosely related topics Word saladβ severe; random words strung together with no meaningful connection Neologismsβ patient invents new words with meaning only to them Clang associationsβ words chosen for their rhyming sound, not meaning Thought blockingβ sudden interruption mid-sentence; patient loses the thought Echolaliaβ meaningless repetition of another person's words Concrete thinkingβ inability to think abstractly; interprets idioms literally (e.g., "raining cats and dogs" = actual animals falling)
π Thought Content Disturbances
Thought insertionβ belief that thoughts are being placed into their mind by an outside force Thought withdrawalβ belief that thoughts are being removed or stolen from their mind Thought broadcastingβ belief that one's thoughts are being transmitted and can be heard by others Ideas of referenceβ belief that external events carry special personal meaning (see Referential Delusions) Depersonalizationβ feeling detached from one's own mental processes or body Derealizationβ environment feels unreal or dreamlike
π‘
When communicating with disorganized patients, use simple, direct sentences, one idea at a time. Repeat key points. Avoid idioms or abstract language β patient may interpret them literally.
π¬
Neurobiology β Why the Brain? Why These Drugs?
β± 14β16 min
β Dopamine Hypothesis
Mesolimbic pathway:excess dopamine activity β positive symptoms(hallucinations, delusions) Mesocortical pathway:deficient dopamine activity β negative symptomsand cognitive deficits Explains why typical antipsychotics (D2 blockers) treat positive symptoms but can worsen negative symptoms Nigrostriatal pathway:D2 blockade here β extrapyramidal side effects (EPS) Tuberoinfundibular pathway:D2 blockade β elevated prolactin β galactorrhea, amenorrhea, sexual dysfunction
π§ͺ Other Neurobiological Factors
Glutamate/NMDA hypothesis:NMDA receptor hypofunction contributes to symptoms; basis for newer treatment targets Structural brain changes:enlarged lateral ventricles (most consistent finding); reduced gray matter volume; hippocampal changes Genetics:strong hereditary component; concordance in identical twins ~50%; first-degree relatives have 10x increased risk Prenatal factors:maternal infections, malnutrition, stress during pregnancy associated with increased risk Onset during period of high synaptic pruning (adolescence/young adulthood)
π
Antipsychotic Medications β 1st vs. 2nd Generation
β± 16β20 min
π
Core Mechanism: Both Generations Block Dopamine D2 Receptors
First-generation (typical) antipsychotics are primarily D2 blockers. Second-generation (atypical) antipsychotics block both D2 and serotonin (5-HT2A) receptors β this dual blockade gives better efficacy for negative symptoms and a lower risk of EPS. Neither generation cures schizophrenia; they manage symptoms.
Feature
π 1st Generation (Typical)
π΅ 2nd Generation (Atypical)
MECHANISM
Primarily D2 receptor blockade
D2 + serotonin (5-HT2A) blockade
KEY DRUGS
haloperidol (Haldol) chlorpromazine (Thorazine) fluphenazine (Prolixin) perphenazine
clozapine (Clozaril) risperidone (Risperdal) olanzapine (Zyprexa) quetiapine (Seroquel) aripiprazole (Abilify) ziprasidone (Geodon)
POSITIVE SYMPTOMS
Effective
Effective
NEGATIVE SYMPTOMS
Minimally effective / may worsen
More effective β major advantage
EPS RISK
GREAT β major concern
Lower (except risperidone at high doses)
METABOLIC SIDE EFFECTS
Moderate
HIGH β weight gain, glucose/lipid abnormalities, metabolic syndrome (especially olanzapine, clozapine)
TARDIVE DYSKINESIA
HIGH risk β long-term use
Lower risk (not zero)
SEDATION
Varies β chlorpromazine very sedating; haloperidol less so
Varies β quetiapine, olanzapine more sedating; aripiprazole less so
PROLACTIN ELEVATION
Significant β amenorrhea, galactorrhea, sexual dysfunction
Less (aripiprazole actually lowers prolactin)
NURSING PRIORITY
Monitor for EPS; teach patient to report muscle stiffness, restlessness, involuntary movements
Monitor metabolic panel; weight, fasting glucose, lipids; clozapine requires ANC monitoring
π‘
Antipsychotics do not work immediately β therapeutic effect takes 2β6 weeks for full benefit. Educate patients and families to continue medication even if they feel no different at first. Stopping medication is the #1 cause of relapse.
β
EPS & NMS β Critical Side Effects
β± 20β24 min
π¨
Extrapyramidal Symptoms (EPS) β Know All Four Types
EPS are movement side effects caused by dopamine D2 blockade in the nigrostriatal pathway. They are most associated with first-generation antipsychotics. Onset timing helps differentiate each type. The nurse must identify EPS early and report immediately β some are reversible; tardive dyskinesia may not be.
Acute Dystonia
ONSET: Hours to days after starting or increasing dose
Sudden, painful muscle spasms and contractions Oculogyric crisisβ eyes roll back involuntarily (very distressing!) Torticollisβ neck twisting to one side Opisthotonos β arching of the back Laryngospasm β airway emergency if severe
Tx: benztropine (Cogentin) IM/IV
or diphenhydramine (Benadryl)
Reversible with treatment
Akathisia
ONSET: Days to weeks after starting
Subjective feeling of extreme inner restlessness Unable to sit still; constant pacing, foot-tapping, shifting Patient describes it as intolerable agitation "from the inside" Often mistaken for anxiety or psychotic agitationβ do not increase antipsychotic! A major cause of medication non-adherence
Tx: propranolol (first choice)
or benzodiazepine
Reduce dose or switch drug
Pseudoparkinsonism
ONSET: Weeks after starting
Drug-induced parkinsonism mimics Parkinson's disease Tremorβ pill-rolling at rest Rigidityβ cogwheel or lead-pipe muscle stiffness Bradykinesiaβ slowed movements Shuffling, festinating gait; mask-like facies (flat expression) Drooling, difficulty swallowing
Tx: benztropine (Cogentin)
or amantadine
Reversible
Tardive Dyskinesia (TD)
ONSET: Months to YEARS of antipsychotic use
Involuntary, repetitive movements from prolonged D2 blockade Classic: lip smacking, tongue protrusion, chewing movementsChoreiform movements of face, limbs, trunk Assessed with AIMS (Abnormal Involuntary Movement Scale)β done at baseline and every 3β6 months May be irreversibleeven after stopping the drug Action: notify provider; consider tapering or switching to atypical
β May be IRREVERSIBLE
Monitor with AIMS scale
Valbenazine (Ingrezza) or deutetrabenazine (Austedo) β FDA approved for TD
π¨
MEDICAL EMERGENCY
Neuroleptic Malignant Syndrome (NMS)
Classic Signs β "FARM"
Fever β high-grade hyperthermia (up to 107Β°F / 41.7Β°C) Autonomic instability β BP fluctuations, tachycardia, diaphoresis, tachypnea Rigidity β severe "lead-pipe" muscle rigidity Mental status change β confusion, altered consciousness, stupor, coma Lab: elevated CPK (creatine phosphokinase)β from muscle breakdown; elevated WBC
Nursing Action & Treatment
STOP the antipsychotic immediatelyβ first and most important action Call provider STAT β this is a medical emergency Transfer to ICU level care Cooling measures β fever management Dantroleneβ muscle relaxant to treat rigidity Bromocriptineβ dopamine agonist to restore dopamine activity IV fluids, supportive care; fatal if untreated
β
Clozapine (Clozaril) β Special Considerations
β± 24β25 min
β
Most Effective Antipsychotic β Reserved for Treatment-Resistant Cases
Clozapine is the most effective antipsychotic available and the only one FDA-approved for treatment-resistant schizophrenia and for reducing suicidal behavior in schizophrenia. However, it carries unique life-threatening risks that require strict monitoring protocols (previously through the Clozapine REMS Program).
β Agranulocytosis β Life-Threatening Risk
Clozapine can cause agranulocytosis (severe reduction in white blood cells β specifically neutrophils) Incidence: approximately 1β2%; can be fatal if undetected Requires mandatory ANC (Absolute Neutrophil Count)monitoring: Weekly for first 6 months β every 2 weeks for months 6β12 β monthly thereafter Drug is dispensed ONLY with compliant ANC results β no lab, no medication Teach patient: report immediately β fever, sore throat, mouth sores, fatigue (signs of agranulocytosis)
π Other Clozapine-Specific Side Effects
Seizuresβ dose-dependent risk; highest concern at higher doses Orthostatic hypotensionβ especially early in treatment; fall risk Hypersalivation (sialorrhea)β excessive drooling; very common and distressing Significant weight gainβ monitor BMI, glucose, lipids closely Sedationβ often significant, especially initially Myocarditis / Cardiomyopathyβ rare but serious; monitor cardiac symptoms Advantage: very low EPS risk; does not raise prolactin significantly
π₯
Nursing Interventions
β± 25β27 min
π€ Therapeutic Relationship & Communication
Maintain a calm, consistent, non-threatening presence Use simple, direct language β one idea per sentence Do not whisper, laugh, or have side conversations near the patient Avoid touch unless patient is comfortable β can be misinterpreted Be honest β never deceive the patient about medications or treatment Maintain appropriate personal space β do not crowd the patient
π‘ Safety & Environment
Assess for command hallucinations and suicidal/homicidal ideation β every shift Provide a structured, predictable environment with consistent routines Reduce environmental stimulation β quiet, low-stimulus milieu during acute phase Remove hazardous objects during acute psychosis Ensure medication is swallowed β observe for "cheeking" (holding medication under tongue) Consider long-acting injectable (LAI) formulations for adherence problems
π Medication Adherence β Priority Concern
Non-adherence is the most common reason for relapse β address every visit Educate patient: medication treats symptoms; stopping leads to relapse Teach: therapeutic effect takes weeks β do not stop if "don't feel different" Discuss and document side effects β address them proactively Use motivational interviewing to explore ambivalence about medications LAI antipsychotics (Haldol decanoate, Risperdal Consta, Abilify Maintena) β monthly/bimonthly injections
β€ Psychosocial Rehabilitation & Recovery
Recovery model: focus on hope, self-determination, and community integration Social skills training β teaching interpersonal skills lost to illness Supported employment / vocational rehabilitation Assertive Community Treatment (ACT) β intensive community-based support teams Family education β NAMI (National Alliance on Mental Illness) support groups Teach family: expressed emotion (hostility, criticism) increases relapse risk β communication skills training
β
CJM Case Study β Clinical Judgment in Action
β± 27β29 min
π Case Scenario
Mr. James T., 24-year-old male, is brought to the psychiatric ED by his mother, who states he has not slept in 4 days, has been refusing to eat ("the government is poisoning the food"), and was found outside talking loudly to himself. He has a diagnosis of schizophrenia and was prescribed risperidone (Risperdal) 3 months ago. His mother states he stopped taking his medication 6 weeks ago because he felt it was "making him stiff and restless." On assessment, James makes poor eye contact, mutters quietly in response to internal stimuli, and suddenly states: "The voices are telling me I have to get out of here β they say I'm in danger."
Command hallucinations β safety concern
Persecutory delusions (food poisoning)
6 weeks med non-adherent
EPS as reason for stopping meds
Prior dx: Schizophrenia
01
STEP 1
Recognize Cues
βΌ
02
STEP 2
Analyze Cues
βΌ
03
STEP 3
Prioritize Hypotheses
βΌ
04
STEP 4
Generate Solutions
βΌ
05
STEP 5
Take Action
βΌ
06
STEP 6
Evaluate Outcomes
βΌ
π―
NCLEX Practice Questions
β± 29β30 min
π
Click an answer to reveal the rationale
Select the best answer for each question. Feedback and rationale are revealed immediately after your selection.
QUESTION 01 Β· SAFETY PRIORITY
A patient with schizophrenia tells the nurse, "The voices are telling me to hurt myself." Which nursing action is the highest priority?
A
Administer the scheduled antipsychotic medication immediately
B
Reassure the patient that the voices are not real and will stop
C
Stay with the patient and perform a thorough safety assessment
D
Notify the family and ask them to come to the facility
QUESTION 02 Β· EPS RECOGNITION
A patient who started haloperidol (Haldol) 2 days ago suddenly reports that his neck is twisting to one side and his eyes are rolling back. He is extremely distressed. The nurse recognizes this as which adverse effect?
A
Akathisia
B
Acute dystonia
C
Tardive dyskinesia
D
Pseudoparkinsonism
QUESTION 03 Β· CLOZAPINE MONITORING
A patient with treatment-resistant schizophrenia has been prescribed clozapine (Clozaril). Which assessment finding requires the nurse to withhold the medication and notify the provider immediately?
A
The patient reports feeling drowsy after each dose
B
The patient has gained 4 pounds since starting the medication
C
The patient complains of excessive drooling at night
D
The patient's ANC result is below the required threshold and a sore throat is reported
QUESTION 04 Β· THERAPEUTIC COMMUNICATION β DELUSIONS
A patient insists that her hospital food is poisoned by government agents and refuses to eat. Which nursing response is most therapeutic?
A
"That's not true. The kitchen staff here are all certified and the food is completely safe."
B
"I understand β those agents sound very dangerous. Let's report them together."
C
"I can see you're feeling unsafe. Would you like to choose a sealed, packaged food that you open yourself?"
D
"You need to eat or we will have to place a feeding tube."
π Based on Videbeck's Psychiatric Mental Health Nursing Β· Chapter 16: Schizophrenia Spectrum Disorders
No PDF was uploaded. Content reflects training knowledge of this textbook. Verify all details against your current edition before teaching.
π Add Note πΎ Save Edited File β Done Editing